Table 3 Subgroup analysis based medical history for relationships between blood soluble IL6 receptor levels and BMD and bone strength in femoral neck.
Variables | Per SD change (95% CI) | P value | Interaction P |
|---|---|---|---|
Femoral neck BMD (g/cm2) | |||
Ever had arthritis | −0.12 (−0.21, −0.03) | 0.008 | 0.348 |
NO | −0.18 (−0.26, −0.09) | < 0.001 | |
Ever had stroke | −0.08 (−0.46, 0.30) | 0.696 | 0.726 |
NO | −0.15 (−0.22, −0.09) | < 0.001 | |
Ever had diabetes | −0.18 (−0.37, 0.00) | 0.058 | 0.525 |
NO | −0.14 (−0.20, −0.07) | < 0.001 | |
Ever had cancer | −0.04 (−0.22, 0.15) | 0.699 | 0.199 |
NO | −0.16 (−0.23, −0.09) | < 0.001 | |
CSI (g/kg m) | |||
Ever had arthritis | 0.01 (−0.08, 0.09) | 0.911 | 0.030 |
NO | −0.13 (−0.22, −0.05) | 0.003 | |
Ever had stroke | −0.18 (−0.63, 0.28) | 0.454 | 0.638 |
NO | −0.07 (−0.13, −0.01) | 0.035 | |
Ever had diabetes | −0.14 (−0.32, 0.03) | 0.108 | 0.409 |
NO | −0.06 (−0.13, 0.01) | 0.098 | |
Ever had cancer | −0.03 (−0.19, 0.13) | 0.735 | 0.654 |
NO | −0.07 (−0.14, −0.00) | 0.042 | |
BSI (g/kg m) | |||
Ever had arthritis | −0.03 (−0.13, 0.06) | 0.479 | 0.236 |
NO | −0.11 (−0.19, −0.03) | 0.008 | |
Ever had stroke | −0.34 (−1.12, 0.43) | 0.394 | 0.206 |
NO | −0.07 (−0.13, −0.01) | 0.019 | |
Ever had diabetes | −0.11 (−0.27, 0.05) | 0.184 | 0.728 |
NO | −0.07 (−0.14, −0.00) | 0.037 | |
Ever had cancer | −0.01 (−0.22, 0.20) | 0.913 | 0.458 |
NO | −0.08 (−0.15, −0.02) | 0.011 | |
ISI (g/kg m) | |||
Ever had arthritis | −0.07 (−0.16, 0.02) | 0.117 | 0.050 |
NO | −0.17 (−0.25, −0.10) | < 0.001 | |
Ever had stroke | −0.15 (−0.72, 0.42) | 0.615 | 0.915 |
NO | −0.13 (−0.18, −0.07) | < 0.001 | |
Ever had diabetes | −0.15 (−0.31, 0.02) | 0.087 | 0.828 |
NO | −0.12 (−0.19, −0.06) | < 0.001 | |
Ever had cancer | −0.03 (−0.22, 0.16) | 0.790 | 0.212 |
NO | −0.14 (−0.20, −0.08) | ||
